Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001319244-20-000020
Filing Date
2020-01-27
Accepted
2020-01-27 16:39:58
Documents
1
Group Members
ICS OPPORTUNITIES II LLCINTEGRATED ASSETS II LLCINTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 ANAB_SC13GA1.htm SC 13G/A 141136
  Complete submission text file 0001319244-20-000020.txt   143311
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

EIN.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Subject) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89797 | Film No.: 20550045
SIC: 2834 Pharmaceutical Preparations